22 results
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
) in its internal control over financial reporting.
(u)The Company’s Board of Directors meets the independence requirements of, and has established … an audit committee that meets the independence requirements of, the rules and regulations of the Commission and The Nasdaq Stock Market LLC (“Nasdaq”).
(v
8-K
EX-3.1
VKTX
Viking Therapeutics Inc
11 May 23
Amendments to Articles of Incorporation or Bylaws
5:00pm
be material to a reasonable stockholder’s understanding of the independence, or lack thereof, of such proposed nominee. If requested by the Corporation … with respect to the proposed nominee’s background, qualification, stock ownership, independence and such other information as may reasonably
PRE 14A
3056yf1o8 qxczte4nc
17 Apr 23
Preliminary proxy
5:04pm
8-K
EX-1.1
4d1glqcmh7
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
8-K
EX-1.1
sgg fhj3b
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
8-K
EX-1.1
ikn8nsonn iht9
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm